Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mother-to-infant transmission of HIV-1: the placenta fights back.

Literature DB >> 11160148

Mother-to-infant transmission of HIV-1: the placenta fights back.

S A Spector¹.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2001 PMID： 11160148 PMCID： PMC199204 DOI： 10.1172/JCI12094

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

19 in total

1. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.

Authors: E E Nakayama; Y Hoshino; X Xin; H Liu; M Goto; N Watanabe; H Taguchi; A Hitani; A Kawana-Tachikawa; M Fukushima; K Yamada; W Sugiura; S I Oka; A Ajisawa; H Sato; Y Takebe; T Nakamura; Y Nagai; A Iwamoto; T Shioda
Journal: J Virol Date: 2000-06 Impact factor: 5.103

2. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Authors: L M Mofenson; J S Lambert; E R Stiehm; J Bethel; W A Meyer; J Whitehouse; J Moye; P Reichelderfer; D R Harris; M G Fowler; B J Mathieson; G J Nemo
Journal: N Engl J Med Date: 1999-08-05 Impact factor: 91.245

3. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.

Authors: L G Kostrikis; A U Neumann; B Thomson; B T Korber; P McHardy; R Karanicolas; L Deutsch; Y Huang; J F Lew; K McIntosh; H Pollack; W Borkowsky; H M Spiegel; P Palumbo; J Oleske; A Bardeguez; K Luzuriaga; J Sullivan; S M Wolinsky; R A Koup; D D Ho; J P Moore
Journal: J Virol Date: 1999-12 Impact factor: 5.103

4. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.

Authors: R E Edelstein; L A Arcuino; J P Hughes; A J Melvin; K M Mohan; P D King; C L McLellan; B L Murante; B P Kassman; L M Frenkel
Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1997-12-01

5. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission.

Authors: K S MacDonald; J Embree; S Njenga; N J Nagelkerke; I Ngatia; Z Mohammed; B H Barber; J Ndinya-Achola; J Bwayo; F A Plummer
Journal: J Infect Dis Date: 1998-03 Impact factor: 5.226

6. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors: L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal: Lancet Date: 1999-09-04 Impact factor: 79.321

7. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice.

Authors: S K De; C R Wohlenberg; N J Marinos; D Doodnauth; J L Bryant; A L Notkins
Journal: J Clin Invest Date: 1997-04-01 Impact factor: 14.808

8. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

Authors: E R Stiehm; J S Lambert; L M Mofenson; J Bethel; J Whitehouse; R Nugent; J Moye; M Glenn Fowler; B J Mathieson; P Reichelderfer; G J Nemo; J Korelitz; W A Meyer; C V Sapan; E Jimenez; J Gandia; G Scott; M J O'Sullivan; A Kovacs; A Stek; W T Shearer; H Hammill
Journal: J Infect Dis Date: 1999-03 Impact factor: 5.226

Mother-to-infant transmission of HIV-1: the placenta fights back.

1. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.

2. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

3. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.

4. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.

5. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission.

6. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

7. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice.

8. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

9. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.

10. Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy.

Review 1. Immunology of pediatric HIV infection.

Review 2. The role of co-infections in mother-to-child transmission of HIV.

Review 3. Host genetic determinants of human immunodeficiency virus infection and disease progression in children.